Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia.

@article{Lscher1986FibromuscularHE,
  title={Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia.},
  author={Thomas Felix L{\"u}scher and Hans-Georg Keller and Hans G. Imhof and Peter Greminger and Ulrich Kuhlmann and Felix Largiad{\`e}r and Ernst Schneider and Jens Schneider and Wilhelm Vetter},
  journal={Nephron},
  year={1986},
  volume={44 Suppl 1},
  pages={109-14}
}
92 patients with fibromuscular hyperplasia (FMH) seen at the University Hospital Zurich were studied. Renovascular FMH was the most frequent manifestation of the disease (89%). FMH of the cerebral arteries was seen in 26%. The intestinal and subclavian arteries were involved in 9% each and the iliac arteries in 5% of the patients. In 2 patients each FMH of the abdominal aorta or the coronary arteries, respectively, was found. 26% of the patients had systemic disease with involvement of 2 or… CONTINUE READING